Page last updated: 2024-11-06

piperonyl butoxide and Status Epilepticus

piperonyl butoxide has been researched along with Status Epilepticus in 1 studies

Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Töpfer, M1
Töllner, K1
Brandt, C1
Twele, F1
Bröer, S1
Löscher, W1

Other Studies

1 other study available for piperonyl butoxide and Status Epilepticus

ArticleYear
Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy.
    The European journal of neuroscience, 2014, Volume: 39, Issue:4

    Topics: Animals; Antioxidants; Brain; Bumetanide; Diuretics; Kainic Acid; Mice; Piperonyl Butoxide; Rats; Ra

2014